InVivo Therapeutics (NSDQ:NVIV) said today it inked a stock purchase agreement with Lincoln Park Capital Fund to sell up to $15 million in shares over a two-year period. The new agreement comes with conditions and limitations, including giving the rights to InVivo to control the timing and amount of sales of stock and that the purchase […]
InVivo Therapeutics
InVivo to end Inspire trial despite meeting primary endpoint, plans new study
InVivo Therapeutics (NSDQ:NVIV) today released updated results from the Inspire study of its neuro-spinal scaffold but said that it would not be reopening enrollment, which it paused last July, and is instead looking to a new randomized controlled trial to supplement the results. The Cambridge, Mass.-based company said that 43.8% of the 16 living patients in the […]
Zimmer Biomet lures Medtronic vet Hanson to CEO spot | Personnel Moves December 19, 2017
Zimmer Biomet (NYSE:ZBH) said today it tapped former Medtronic (NYSE:MDT) exec VP Bryan Hanson as its new prez and CEO, replacing interim CEO Daniel Florin who will continue on as CFO and senior VP. A 20-year veteran of medical devices, Hanson operated most recently as group president of Fridley, Minn.-based Medtronic’s approximately $9 billion minimally invasive […]
InVivo pulls trigger on $2m warrant exchange
InVivo Therapeutics (NSDQ:NVIV) said today it exchanged outstanding warrants, issued as part of a financing in 2014, for 2 million new shares of common stock. The exchange is worth approximately $2.4 million, given InVivo’s current share price of $1.20 as of 10:44 a.m. EDT. InVivo said it negotiated individual exchange agreements with warrant holders, and that […]
InVivo adds 34th site to Inspire neuro-spinal scaffold trial
InVivo Therapeutics (NSDQ:NVIV) said today it added Stanford Medicine as the 34th clinical in the Inspire study of its neuro-spinal scaffold. The Cambridge, Mass.-based company’s neuro-spinal scaffold is a novel, biodegradable device designed to be surgically implanted following acute spinal cord injuries to act as a physical substrate for nerve sprouting. Dr. Atman Desai has been […]
InVivo adds 1st UK site to Inspire neuro-spinal scaffold study
InVivo Therapeutics (NSDQ:NVIV) said today it added its 1st UK-based site to the Inspire study of its neuro-spinal scaffold at Middlesbrough’s James Cook University Hospital, bringing the total number of sites up to 33. The Cambridge, Mass.-based company’s neuro-spinal scaffold is designed to be surgically implanted following acute spinal cord injuries to act as a physical […]
7 medtech stories we missed this week: July 7, 2017
From EnvisionTEC’s FDA approval to InVivo Therapeutics adding a new clinical site, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. EnvisionTEC wins FDA nod for 3D printing E-Denture material EnvisionTEC announced in a June 30 press release that it has received FDA approval for its E-Denture material […]
InVivo touts 2 patient recoveries in Inspire trial
InVivo Therapeutics (NSDQ:NVIV) said today that 2 patients in the Inspire trial of its neuro-spinal scaffold have shown significant improvements in motor recovery assessments. The Cambridge, Mass.-based company’s neuro-spinal scaffold is designed to be surgically implanted following acute spinal cord injuries to act as a physical substrate for nerve sprouting. InVivo said that the 2 patients […]
InVivo enrolls 17th patient in Inspire trial
InVivo Therapeutics (NSDQ:NVIV) said today it enrolled yet another patient in the Inspire study of its neuro-spinal scaffold, bringing the total enrolled up to 17. The Cambridge, Mass.-based company’s neuro-spinal scaffold is designed to be surgically implanted following acute spinal cord injuries to act as a physical substrate for nerve sprouting. “We are pleased to hear that […]
InVivo enrolls 16th patient in neuro-spinal scaffold study
InVivo Therapeutics (NSDQ:NVIV) said today it enrolled the 16th patient in the Inspire study of its neuro-spinal scaffold. The Cambridge, Mass.-based company’s neuro-spinal scaffold is designed to be surgically implanted following acute spinal cord injuries to act as a physical substrate for nerve sprouting. The patient was enrolled at Pittsburgh, Penn.’s Allegheny General Hospital after Drs. […]
InVivo adds Reeve Foundation database to Contempo registry study
InVivo Therapeutics (NSDQ:NVIV) said today it will integrate data from the Christopher & Dana Reeve Foundation’s North American Clinical Trials Network Registry in the Contempo registry study which is complementing its ongoing Inspire study. The Cambridge, Mass.-based company said that the Contempo study looks to provide comprehensive natural history benchmarks for the Inspire study of its […]